Oncopharmpod
Tivozanib (and More)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:18:09
- Mas informaciones
Informações:
Sinopsis
Tivozanib's FDA approval for mRCC was a long time in the making, but what is its role? Disappointing atezolizumab results for adjuvant treatment of bladder cancer (IMvigor-010). Preliminary data on antibody responses to COVID-19 vaccination in cancer patients.
